Search by Drug Name or NDC
NDC 50228-0109-30 CARISOPRODOL 350 mg/1 Details
CARISOPRODOL 350 mg/1
CARISOPRODOL is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ScieGen Pharmaceuticals, Inc.. The primary component is CARISOPRODOL.
MedlinePlus Drug Summary
Carisoprodol is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Carisoprodol is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.
Related Packages: 50228-0109-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Carisoprodol
Product Information
| NDC | 50228-0109 |
|---|---|
| Product ID | 50228-109_f1b2306e-24ae-607d-e053-2a95a90aa908 |
| Associated GPIs | 75100020000305 |
| GCN Sequence Number | 004663 |
| GCN Sequence Number Description | carisoprodol TABLET 350 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17912 |
| HICL Sequence Number | 001944 |
| HICL Sequence Number Description | CARISOPRODOL |
| Brand/Generic | Generic |
| Proprietary Name | CARISOPRODOL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CARISOPRODOL |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 350 |
| Active Ingredient Units | mg/1 |
| Substance Name | CARISOPRODOL |
| Labeler Name | ScieGen Pharmaceuticals, Inc. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA203374 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50228-0109-30 (50228010930)
| NDC Package Code | 50228-109-30 |
|---|---|
| Billing NDC | 50228010930 |
| Package | 30 TABLET in 1 BOTTLE (50228-109-30) |
| Marketing Start Date | 2014-01-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |